Soluble guanylate cyclase crystal clear: 1st crystal structure of the wild-type human heterodimeric sGC catalytic domains and implications for activity

Thumbnail Image

Files

Binder1.pdf (943.05 KB)

Links to Files

https://link.springer.com/article/10.1186%2F2050-6511-14-S1-O14#citeas

Permanent Link

https://doi.org/10.1186/2050-6511-14-S1-O14
 http://hdl.handle.net/11603/17467

Collections

UMBC Chemistry & Biochemistry Department
UMBC Faculty Collection

Author/Creator

Author/Creator ORCID

Date

2013-08-29

Type of Work

presentations (communicative events)
Text

Department

Program

Citation of Original Publication

Seeger, F., Garcin, E.D. Soluble guanylate cyclase crystal clear: 1st crystal structure of the wild-type human heterodimeric sGC catalytic domains and implications for activity. BMC Pharmacol Toxicol 14, O14 (2013). https://doi.org/10.1186/2050-6511-14-S1-O14

Rights

This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
Attribution 3.0 United States

Subjects

Abstract

Soluble guanylate cyclase (sGC) is the key enzyme in the NO-sGC-cGMP signaling cascade crucial in regulating the cardiovascular system. Low output of this system causes hypertension and acute heart failure, which are the leading causes of death globally. Mammalian sGC is a heterodimer of two homologous subunits (α and β), which contain four domains: an N-terminal regulatory domain (HNOX: Heme Nitric oxide OXygen), an HNOX associated (HNOXA) domain and a coiled-coil (CC) domain important for dimerization, and a C-terminal catalytic domain (GC) (Figure 1). The enzyme is basally active, but NO binding to the heme group in the β subunit regulatory domain enhances sGC catalytic output several hundred fold. The molecular mechanism by which the regulatory domain relays the activation signal to the catalytic domain remains elusive. Several studies have highlighted the crucial role of the HNOXA and CC domains for sGC dimerization necessary for catalytic activity [1–9]. Others have shown that the C-terminal GC domains, alone, form catalytically active heterodimers that are inhibited in the presence of the βHNOX regulatory domain [10]. Clearly, more information is needed to elucidate the requirements for sGC activity and activation. We have established a bacterial overexpression system for truncated constructs of sGC containing the catalytic domains. These constructs can be probed for activity and structurally characterized for conformational changes that may occur during activation.